Eusol Biotech Co.,Ltd. (UNQ: 6652)
Health Care · Biotechnology · TW
NT$—
— today · — 1Y
Eusol Biotech Co.,Ltd. (UNQ: 6652) operates in the Biotechnology industry within the Health Care sector. The company is valued at $8.45M and employs 9 people.
trading between 1.87 and 10.20.
Tweenvest scores Eusol Biotech Co.,Ltd. across four factors: quality 41/100, value 44/100. Its strongest factor is value.
6652 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.45M
- Revenue (TTM)
- $66.14K
- P/E
- —
- EPS
- -0.30
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$10.20
- 52-week low
- NT$1.87
- Avg volume (3M)
- —
- Shares outstanding
- 137.00M
- Employees
- 9
- Next earnings
- —
About Eusol Biotech Co.,Ltd.
Eusol Biotech Co.,Ltd. focuses on research and development of new biotech drugs for sleep disorders. Its pipeline includes ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) for repairing neuron function; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with sedative effect. The company was founded in 1994 and is headquartered in Taipei, Taiwan.
- ISIN
- TW0006652001
- Founded
- 1994
- Listed since
- Aug 29, 2018
- Exchange
- Unquoted Security
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hemostemix Inc.TSXV: HEM | $8.90M | CA$0.08 | +25.00% |
| 1nKemia IUCT Group, S.A.BME: IKM | $8.80M | €— | — |
| Aprea Therapeutics, Inc.NasdaqCM: APRE | $8.75M | $0.56 | -19.68% |
| FibroBiologics, Inc.NasdaqCM: FBLG | $8.63M | $1.11 | -10.48% |
| Rakovina Therapeutics Inc.TSXV: RKV | $8.45M | CA$0.23 | -14.81% |
| Cizzle Biotechnology Holdings PlcLSE: CIZ | $8.43M | £0.01 | -3.33% |
| OSR Health, Inc.OTCPK: OSRH | $8.43M | $0.24 | +6.67% |
| Longeveron Inc.NasdaqCM: LGVN | $8.23M | $2.37 | -8.14% |
Figures last refreshed Oct 4, 2026.